Aveo's tivozanib, now approved as Fotivda, will hit the market after years of setbacks

Retrieved on: 2021-03-11 17:16:23

Tags for this article:

Click the tags to see associated articles and topics

Aveo's tivozanib, now approved as Fotivda, will hit the market after years of setbacks. View article details on hiswai:

Excerpt

The analysts project $417 million in peak sales. ... and most recently served as senior vice president, business analytics and commercial operations.

Article found on: www.fiercepharma.com